EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil
Collins MH, Potter GE, Hitchings MDT, Butler E, Wiles M, Kennedy JK, Pinto SB, Teixeira ABM, Casanovas-Massana A, Rouphael NG, Deye GA, Simmons CP, Moreira LA, Nogueira ML, Cummings DAT, Ko AI, Teixeira MM, Edupuganti S. EVITA Dengue: a cluster-randomized controlled trial to EValuate the efficacy of Wolbachia-InfecTed Aedes aegypti mosquitoes in reducing the incidence of Arboviral infection in Brazil. Trials 2022, 23: 185. PMID: 35236394, PMCID: PMC8889395, DOI: 10.1186/s13063-022-05997-4.Peer-Reviewed Original ResearchMeSH KeywordsAedesAnimalsBrazilChildDengueDengue VirusHumansIncidenceMosquito VectorsWolbachiaZika VirusZika Virus InfectionConceptsArboviral infectionsMajor global health problemHigh-quality evidenceCluster-randomized trialGlobal health problemNational InstituteEfficacy of WolbachiaWorld Mosquito ProgramArbovirus transmissionOngoing trialsLicensed antiviralsAedes aegypti mosquitoesEffective vaccineTrial designMosquito ProgramSerologic surveillanceHealth problemsHuman infectionsAedes aegyptiInfectionEpidemiologic outcomesVector control activitiesTrialsAegypti mosquitoesAedes mosquitoes
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply